UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 67,288 Grail, Inc. (NASDAQ:GRAL)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 67,288 shares of the company's stock, valued at approximately $1,201,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.20% of Grail at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in GRAL. Lindbrook Capital LLC acquired a new position in shares of Grail during the fourth quarter valued at about $28,000. State of Tennessee Department of Treasury acquired a new position in shares of Grail during the fourth quarter valued at about $28,000. Sterling Capital Management LLC acquired a new position in shares of Grail during the fourth quarter valued at about $29,000. Wellington Shields Capital Management LLC acquired a new position in shares of Grail during the fourth quarter valued at about $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Grail during the fourth quarter valued at about $41,000.

Grail Stock Down 1.5%

Grail stock traded down $0.61 during midday trading on Friday, hitting $41.31. 762,324 shares of the stock were exchanged, compared to its average volume of 1,264,413. The stock has a market capitalization of $1.49 billion and a price-to-earnings ratio of -0.68. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99. The business's 50-day moving average price is $34.66 and its 200-day moving average price is $29.84.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. The business had revenue of $31.84 million during the quarter, compared to the consensus estimate of $35.80 million. On average, sell-side analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Aaron Freidin sold 41,150 shares of the stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $1,396,219.50. Following the transaction, the chief financial officer now owns 294,020 shares of the company's stock, valued at $9,976,098.60. This represents a 12.28% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, President Joshua J. Ofman sold 48,213 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,635,867.09. Following the completion of the transaction, the president now directly owns 511,460 shares in the company, valued at $17,353,837.80. The trade was a 8.61% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 183,398 shares of company stock valued at $6,222,694. Company insiders own 1.85% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on GRAL shares. Morgan Stanley boosted their price target on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th. Canaccord Genuity Group boosted their price target on shares of Grail from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.